Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Wissing S, Galloway NL, Greene WC.

Mol Aspects Med. 2010 Oct;31(5):383-97. doi: 10.1016/j.mam.2010.06.001. Epub 2010 Jun 9. Review.

2.

Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.

Ara A, Love RP, Follack TB, Ahmed KA, Adolph MB, Chelico L.

J Virol. 2017 Jan 18;91(3). pii: e02230-16. doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.

PMID:
27881650
3.

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.

PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17.

4.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
5.

The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.

Binka M, Ooms M, Steward M, Simon V.

J Virol. 2012 Jan;86(1):49-59. doi: 10.1128/JVI.06082-11. Epub 2011 Oct 19.

6.

Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.

Baig TT, Feng Y, Chelico L.

J Virol. 2014 Dec;88(24):14380-95. doi: 10.1128/JVI.02484-14. Epub 2014 Oct 1. Erratum in: J Virol. 2017 Mar 13;91(7):.

7.

Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.

Zhang W, Huang M, Wang T, Tan L, Tian C, Yu X, Kong W, Yu XF.

Cell Microbiol. 2008 Aug;10(8):1662-75. doi: 10.1111/j.1462-5822.2008.01157.x. Epub 2008 Apr 16.

8.

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Albin JS, Harris RS.

Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Review.

9.

HIV-1 Vif, APOBEC, and intrinsic immunity.

Goila-Gaur R, Strebel K.

Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51. Review.

10.

Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.

Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y.

J Virol. 2014 Mar;88(6):3309-19. doi: 10.1128/JVI.03824-13. Epub 2014 Jan 3.

11.

Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

Albin JS, Anderson JS, Johnson JR, Harjes E, Matsuo H, Krogan NJ, Harris RS.

J Mol Biol. 2013 Apr 12;425(7):1172-82. doi: 10.1016/j.jmb.2013.01.010. Epub 2013 Jan 11.

12.

The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.

Richards C, Albin JS, Demir Ö, Shaban NM, Luengas EM, Land AM, Anderson BD, Holten JR, Anderson JS, Harki DA, Amaro RE, Harris RS.

Cell Rep. 2015 Dec 1;13(9):1781-8. doi: 10.1016/j.celrep.2015.10.067. Epub 2015 Nov 25.

13.

Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.

Siu KK, Sultana A, Azimi FC, Lee JE.

Nat Commun. 2013;4:2593. doi: 10.1038/ncomms3593.

14.

Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Bohn MF, Shandilya SM, Albin JS, Kouno T, Anderson BD, McDougle RM, Carpenter MA, Rathore A, Evans L, Davis AN, Zhang J, Lu Y, Somasundaran M, Matsuo H, Harris RS, Schiffer CA.

Structure. 2013 Jun 4;21(6):1042-50. doi: 10.1016/j.str.2013.04.010. Epub 2013 May 16.

15.

Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.

Dang Y, Wang X, York IA, Zheng YH.

J Virol. 2010 Sep;84(17):8561-70. doi: 10.1128/JVI.00960-10. Epub 2010 Jun 30.

16.

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.

Zhang W, Du J, Evans SL, Yu Y, Yu XF.

Nature. 2011 Dec 21;481(7381):376-9. doi: 10.1038/nature10718.

PMID:
22190036
17.

Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.

Refsland EW, Hultquist JF, Harris RS.

PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.

20.

HIV restriction by APOBEC3 in humanized mice.

Krisko JF, Martinez-Torres F, Foster JL, Garcia JV.

PLoS Pathog. 2013 Mar;9(3):e1003242. doi: 10.1371/journal.ppat.1003242. Epub 2013 Mar 28.

Supplemental Content

Support Center